• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经流利型与 Viatorr 支架型经颈静脉肝内门体分流术(TIPS)创建治疗的临床转归:单中心回顾性研究。

Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation Using Fluency Versus Viatorr Stent-Grafts: A Single-Centre Retrospective Study.

机构信息

Gastroenterology Department II, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650101, Yunnan, China.

Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650101, Yunnan, China.

出版信息

Cardiovasc Intervent Radiol. 2022 May;45(5):552-562. doi: 10.1007/s00270-022-03102-5. Epub 2022 Mar 10.

DOI:10.1007/s00270-022-03102-5
PMID:35274174
Abstract

PURPOSE

To investigate the effects of transjugular intrahepatic portosystemic shunt (TIPS) creation using Fluency versus Viatorr stent-grafts on the long-term clinical outcomes.

MATERIALS AND METHODS

This was a single-center retrospective study from January 2010 to October 2021 in 213 patients receiving TIPS with Fluency (Fluency group, n = 154) versus Viatorr (Viatorr group, n = 59) stent-grafts. Inclusion criteria were: age > 18 years old and TIPS creation for variceal hemorrhage. Exclusion criteria were: age > 80 years old, concomitant chronic heart or lung disease, active tuberculosis or human immunodeficiency virus infection, extrahepatic malignancy, alcohol dependence, TIPS created outside of our hospital, without any follow-up data, or decline to participate. The primary outcome was primary patency rate and its associated risk factors.

RESULTS

The 5-year cumulative primary patency rate was significantly higher in Viatorr group than in Fluency group (89.0% vs. 19.6%, p < 0.001), whereas the 5-year cumulative transplant-free survival rate (62.3% vs. 62.2%, p = 0.636) was comparable between two groups. Cox-regression models revealed that group (hazard ratio [HR]4.029, 95% confidence interval [CI] 1.486-10.927, p = 0.006), use of bare stents (HR 3.307, 95% CI 1.903-5.747, p < 0.001), and baseline portal vein thrombosis (HR 0.248, 95% CI 0.149-0.412, p < 0.001) were significantly associated with shunt patency. Incidences of adverse events were not significantly different between two groups (p > 0.05).

CONCLUSIONS

TIPS creation using Viatorr stent-grafts is superior to using Fluency stent-grafts in terms of higher long-term primary patency rate but similar transplant-free survival rate.

摘要

目的

研究使用 Fluency 与 Viatorr 支架行经颈静脉肝内门体分流术(TIPS)对长期临床结果的影响。

材料与方法

这是一项单中心回顾性研究,纳入 2010 年 1 月至 2021 年 10 月在我院接受 TIPS 的 213 例患者,其中使用 Fluency(Fluency 组,n=154)与 Viatorr(Viatorr 组,n=59)支架。纳入标准为:年龄>18 岁且因静脉曲张出血而行 TIPS。排除标准为:年龄>80 岁、合并慢性心肺疾病、活动性肺结核或人类免疫缺陷病毒感染、肝外恶性肿瘤、酒精依赖、TIPS 非在我院创建、无任何随访数据或拒绝参与。主要结局为初始通畅率及其相关的危险因素。

结果

Viatorr 组的 5 年累积初始通畅率显著高于 Fluency 组(89.0%比 19.6%,p<0.001),而两组的 5 年无移植生存率(62.3%比 62.2%,p=0.636)相似。Cox 回归模型显示,分组(风险比[HR]4.029,95%置信区间[CI]1.486-10.927,p=0.006)、使用裸支架(HR 3.307,95%CI 1.903-5.747,p<0.001)和基线门静脉血栓形成(HR 0.248,95%CI 0.149-0.412,p<0.001)与分流通畅显著相关。两组不良事件发生率无显著差异(p>0.05)。

结论

与 Fluency 支架相比,使用 Viatorr 支架行 TIPS 具有更高的长期初始通畅率,但无移植生存率相似。

相似文献

1
Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation Using Fluency Versus Viatorr Stent-Grafts: A Single-Centre Retrospective Study.经流利型与 Viatorr 支架型经颈静脉肝内门体分流术(TIPS)创建治疗的临床转归:单中心回顾性研究。
Cardiovasc Intervent Radiol. 2022 May;45(5):552-562. doi: 10.1007/s00270-022-03102-5. Epub 2022 Mar 10.
2
Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.覆膜自膨式 Viatorr CX 支架与覆膜球囊扩张 BeGraft 外周支架在经颈静脉肝内门体分流术(TIPS)中的比较:一项静脉曲张出血患者的单中心回顾性研究。
Cardiovasc Intervent Radiol. 2022 May;45(5):542-549. doi: 10.1007/s00270-021-03040-8. Epub 2022 Jan 12.
3
Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.经 Fluent 支架型分流器经颈静脉肝内门体分流术治疗的静脉曲张出血患者的分流功能障碍和总体生存的预测因素。
Acad Radiol. 2018 Jul;25(7):925-934. doi: 10.1016/j.acra.2017.11.020. Epub 2018 Jan 17.
4
Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.用于经颈静脉肝内门体分流术创建的Viatorr膨体聚四氟乙烯覆膜支架移植物的回顾性多中心试验结果。
J Vasc Interv Radiol. 2004 Nov;15(11):1219-30. doi: 10.1097/01.RVI.0000137434.19522.E5.
5
Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation.比较专用支架与通用支架和裸支架联合用于经颈静脉肝内门体分流术的创建。
Sci Rep. 2024 Jun 23;14(1):14439. doi: 10.1038/s41598-024-64358-0.
6
Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.经聚四氟乙烯扩张型支架建立经颈静脉肝内门体分流术的长期通畅率和临床结果。
PLoS One. 2019 Feb 27;14(2):e0212658. doi: 10.1371/journal.pone.0212658. eCollection 2019.
7
6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.6毫米分流的经颈静脉肝内门体分流术用于治疗严重肝萎缩和静脉曲张出血患者。
Eur Radiol. 2024 Jul;34(7):4697-4707. doi: 10.1007/s00330-023-10346-3. Epub 2023 Nov 25.
8
Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.使用Viatorr膨体聚四氟乙烯覆膜支架移植物建立经颈静脉肝内门体分流术。
J Vasc Interv Radiol. 2004 Mar;15(3):239-48. doi: 10.1097/01.rvi.0000116194.44877.c1.
9
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.使用新型VIATORR®可控扩张支架进行控制性扩张不足可提高经颈静脉肝内门体分流术植入后的生存率。
JHEP Rep. 2021 Mar 3;3(3):100264. doi: 10.1016/j.jhepr.2021.100264. eCollection 2021 Jun.
10
Portal Vein Recanalization for Noncirrhotic Portal Vein Cavernous Transformation: Transjugular Intrahepatic Portosystemic Shunt Creation versus Portal Vein Stent Placement.非肝硬化门静脉海绵样变的门静脉再通:经颈静脉肝内门体分流术与门静脉支架置入术的比较
J Vasc Interv Radiol. 2023 Feb;34(2):187-194. doi: 10.1016/j.jvir.2022.10.039. Epub 2022 Nov 7.

引用本文的文献

1
Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation.比较专用支架与通用支架和裸支架联合用于经颈静脉肝内门体分流术的创建。
Sci Rep. 2024 Jun 23;14(1):14439. doi: 10.1038/s41598-024-64358-0.
2
Shunt dysfunction patterns after transjugular intrahepatic portosystemic shunt creation using a combination of a generic stent-graft and bare-stents.使用通用覆膜支架和裸支架组合创建经颈静脉肝内门体分流术后的分流功能障碍模式
CVIR Endovasc. 2024 Jan 10;7(1):7. doi: 10.1186/s42155-023-00421-7.
3
Commentary on Ethanol Embolization of Nasal Arteriovenous Malformations: A Ten-Year, Single Institution Experience.
鼻腔动静脉畸形乙醇栓塞治疗的评论:十年单机构经验
Cardiovasc Intervent Radiol. 2022 Apr;45(4):486-487. doi: 10.1007/s00270-022-03082-6. Epub 2022 Feb 15.